# ZYNLONTA

NDC: 79952-110
Generic name: loncastuximab tesirine
Labeler / Manufacturer: ADC Therapeutics America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210430

FDA application: BLA761196

## Active ingredients

- LONCASTUXIMAB TESIRINE: 10 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"79952-110"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=79952-110
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af54af12-3edf-4301-8bc5-0446bc813c1d